Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) Operating Expenses (2020 - 2025)

Historic Operating Expenses for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to $3.2 million.

  • IceCure Medical's Operating Expenses rose 1491.2% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.1 million, marking a year-over-year increase of 169.03%. This contributed to the annual value of $11.0 million for FY2024, which is 1333.02% down from last year.
  • IceCure Medical's Operating Expenses amounted to $3.2 million in Q3 2025, which was up 1491.2% from $2.7 million recorded in Q2 2025.
  • IceCure Medical's Operating Expenses' 5-year high stood at $4.1 million during Q1 2022, with a 5-year trough of $1.8 million in Q1 2021.
  • For the 5-year period, IceCure Medical's Operating Expenses averaged around $3.0 million, with its median value being $2.9 million (2024).
  • As far as peak fluctuations go, IceCure Medical's Operating Expenses soared by 12420.94% in 2022, and later crashed by 2508.24% in 2024.
  • IceCure Medical's Operating Expenses (Quarter) stood at $3.1 million in 2021, then rose by 11.59% to $3.4 million in 2022, then dropped by 18.85% to $2.8 million in 2023, then fell by 3.38% to $2.7 million in 2024, then grew by 19.02% to $3.2 million in 2025.
  • Its Operating Expenses stands at $3.2 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.6 million for Q1 2025.